Key Dates

Related Announcements

RFA-DA-23-060 - HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional)

RFA-DA-23-059 - HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice is to inform potential applicants that the Division of Neuroscience and Behavior (DNB) at the National Institute on Drug Abuse (NIDA) will host a pre-application webinar on Tuesday, January 10, 2023, from 12:00 p.m. to 1:00 p.m. (Eastern Daylight Time, EDT) for those interested in learning more about RFA-DA-23-059 HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional) and RFA-DA-23-060 HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Coordinating Center (U01 Clinical Trial Optional). Staff from NIDA and the other Institutes and Centers participating in the RFA (the National Heart Lung and Blood Institute [NHLBI], National Institute on Alcohol Abuse and Alcoholism [NIAAA] and the National Center for Complementary and Integrative Health [NCCIH]) will review RFA-DA-23-059 and RFA-DA-23-060 and answer questions from prospective applicants. Details on how to attend and submit questions will soon be available on the NIDA Meetings and Events page.

Participation in the webinar is not required to submit an application. We plan to post a recording of the webinar on the NIDA Meetings and Events page after the meeting.

Inquiries

Please direct all inquiries to:

Sunila Nair, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6832
Email: sunila.nair@nih.gov

Aaron D. Laposky, PhD
National Heart, Lung, Blood Institute (NHLBI)
Telephone: 301-827-7837
Email: laposkya@nhlbi.nih.gov